LRRTM3 Gene

Migration, Crosslink

📖

LRRTM3 Gene

active

wiki page Created: 2026-04-02T07:19:29 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-lrrtm3

📖 Wiki Page

gene2582 wordssynced 2026-04-02

title: LRRTM3 Gene

LRRTM3 (Leucine-Rich Repeat Transmembrane Neuronal 3)

| Property | Value |
|----------|-------|
| Gene Symbol | LRRTM3 |
| Full Name | Leucine-Rich Repeat Transmembrane Neuronal 3 |
| Chr Location | 10q21.3 |
| NCBI Gene ID | 285220 |
| OMIM ID | 611242 |
| Ensembl ID | ENSG00000163220 |
| UniProt ID | Q86VH5 |
| Encoded Protein | LRRTM3 |
| Associated Diseases | Alzheimer's disease, autism spectrum disorder, visual processing disorders, bipolar disorder |

</div>

Overview

LRRTM3 (Leucine-Rich Repeat Transmembrane Neuronal 3) is a synaptic adhesion molecule that plays a critical role in excitatory synapse formation and function. Located on chromosome 10q21.3, LRRTM3 is a member of the LRRTM family of leucine-rich repeat transmembrane proteins that regulate synaptic development in the central nervous system. LRRTM3 has distinct binding properties compared to other LRRTM family members and has specialized functions in specific neural circuits, particularly in the hippocampus and visual pathway.

The gene has garnered significant attention in neurodegenerative research due to its genetic association with late-onset Alzheimer's disease (LOAD) and its role in regulating amyloid precursor protein (APP) processing.[@lincoln2013] Additionally, rare genetic variants in LRRTM[@dutta2023]3 have been implicated in autism spectrum disorder (ASD) and bipolar disorder, highlighting its importance in synaptic function and neurological disease pathogenesis [1][2][3].

...

title: LRRTM3 Gene

LRRTM3 (Leucine-Rich Repeat Transmembrane Neuronal 3)

| Property | Value |
|----------|-------|
| Gene Symbol | LRRTM3 |
| Full Name | Leucine-Rich Repeat Transmembrane Neuronal 3 |
| Chr Location | 10q21.3 |
| NCBI Gene ID | 285220 |
| OMIM ID | 611242 |
| Ensembl ID | ENSG00000163220 |
| UniProt ID | Q86VH5 |
| Encoded Protein | LRRTM3 |
| Associated Diseases | Alzheimer's disease, autism spectrum disorder, visual processing disorders, bipolar disorder |

</div>

Overview

LRRTM3 (Leucine-Rich Repeat Transmembrane Neuronal 3) is a synaptic adhesion molecule that plays a critical role in excitatory synapse formation and function. Located on chromosome 10q21.3, LRRTM3 is a member of the LRRTM family of leucine-rich repeat transmembrane proteins that regulate synaptic development in the central nervous system. LRRTM3 has distinct binding properties compared to other LRRTM family members and has specialized functions in specific neural circuits, particularly in the hippocampus and visual pathway.

The gene has garnered significant attention in neurodegenerative research due to its genetic association with late-onset Alzheimer's disease (LOAD) and its role in regulating amyloid precursor protein (APP) processing.[@lincoln2013] Additionally, rare genetic variants in LRRTM[@dutta2023]3 have been implicated in autism spectrum disorder (ASD) and bipolar disorder, highlighting its importance in synaptic function and neurological disease pathogenesis [1][2][3].

Molecular Structure and Biochemistry

Protein Architecture

LRRTM3 encodes a type I transmembrane protein with a distinct domain structure that mediates its synaptic functions:

Signal Peptide (1-20 aa): N-terminal secretion signal that directs the protein to the secretory pathway
Leucine-Rich Repeat (LRR) Domain (21-280 aa): Ten LRR motifs forming a curved solenoid structure that mediates protein-protein interactions
Fibronectin Type III (FNIII) Domain (281-400 aa): Additional extracellular interaction domain
Transmembrane Region (401-423 aa): Single-pass membrane anchor
Cytoplasmic Tail (424-523 aa): Intracellular domain involved in signaling cascades

The LRR domain is the primary [@roppongi2020]mediator of LRRTM3's synaptic adhesion functions, enabling binding to presynaptic partners including neurexin and the protein tyrosine phosphatase PTPσ [4]. This binding is regulated by alternative splicing, particularly at the splice site 4 (SS4) of presynaptic neurexin, which modulates the strength and specificity of synaptic connections [2].

Isoforms and Alternative Splicing

Multiple LRRTM3 isoforms have been identified, with the canonical isoform encoding a 523-amino acid protein. Alternative splicing generates variants with different extracellular domain configurations, potentially affecting ligand binding specificity.[@um2016] The splice variants exhibit differential expression patterns across brain regions, suggesting tissue-specific regulation of LRRTM3 function [2][10].

Physiological Functions

Excitatory Synapse Formation

LRRTM3 is a key organizer of excitatory synapses, functioning through both presynaptic and postsynaptic mechanisms. Unlike other LRRTM family members, LRRTM3 exhibits unique binding properties that enable specialized roles in specific neural circuits.

Postsynaptic Mechanisms:

Induces postsynaptic specialization at nascent synapses
Recruits and clusters AMPA-type glutamate receptors (AMPARs) at the postsynaptic density
Interacts with PSD-95 family proteins to anchor receptors at the postsynaptic membrane
Regulates synaptic strength through activity-dependent modulation of receptor trafficking

Presynaptic Differentiation:

Induces presynaptic differentiation in contacting axons
Regulates vesicle release probability at excitatory synapses
Controls activity-dependent synchronization of presynaptic and postsynaptic properties [1]

Hippocampal Circuit Development

LRRTM3 plays a crucial role in regulating activity-dependent synchronization of synapse properties in topographically connected hippocampal neural circuits [1]. The gene regulates:

Synaptic vesicle dynamics at hippocampal mossy fiber synapses
Temporal precision of neurotransmission
Circuit-specific refinement of excitatory connections

Research by Kim et al. (2022) demonstrated that LRRTM3 is essential for maintaining synchronized synaptic properties across topographically organized hippocampal circuits, suggesting a role in information coding and storage [1].

Thalamic Reticular Circuit Development

Recent work by Lee et al. (2026) revealed that LRRTM3 enables juvenile-to-adult refinement of thalamic reticular circuits, which is critical for high-resolution sensory encoding [8]. This finding establishes LRRTM3 as a key regulator of sensory processing circuitry maturation.

Visual Pathway Development

LRRTM3 is highly expressed in visual processing regions and contributes to retinogeniculate connectivity. The protein's role in visual circuit development may explain its association with visual processing disorders [9].

Role in Alzheimer's Disease

Genetic Association

LRRTM3 was originally identified as a positional candidate gene for late-onset Alzheimer's disease through genetic linkage studies. Initial studies by Majercak et al. (2006) demonstrated that LRRTM3 promotes processing of amyloid precursor protein (APP) by beta-secretase (BACE1), positioning it at the intersection of amyloidogenesis and synaptic function [5].

Follow-up research by Lincoln et al. (2013) confirmed that LRRTM3 interacts with both APP and BACE1, and identified genetic variants in LRRTM3 that associate with late-onset Alzheimer's disease [4]. These findings suggest that LRRTM3 may influence AD risk through its effects on amyloid-beta production.

APP Processing

LRRTM3 regulates APP metabolism through multiple mechanisms:

Direct interaction with the APP intracellular domain
Colocalization with BACE1 in synaptic compartments
Modulation of secretase activity at the synapse
Regulation of APP trafficking between cellular compartments

Amyloid-Beta Production

Despite initial evidence suggesting LRRTM3 promotes amyloid-beta production, studies in knock-out mice showed that LRRTM3 is dispensable for amyloid-beta production in vivo [9]. This suggests that compensatory mechanisms may exist, or that LRRTM3's role in AD is more complex than initially hypothesized.

Synaptic Dysfunction in AD

The synaptic dysfunction observed in Alzheimer's disease may involve LRRTM3 through several mechanisms:

Altered LRRTM3 expression in AD brain tissue
Dysregulation of synaptic adhesion in the presence of amyloid-beta oligomers
Impaired activity-dependent synaptic modification
Disruption of hippocampal circuit function

Role in Autism Spectrum Disorder

Genetic Evidence

Dutta et al. (2023) identified specific LRRTM3 genetic variants (rs1925575 and rs1925608) that contribute to autism spectrum disorder trait severity [3]. These findings support a role for LRRTM3 in synaptic dysfunction mechanisms underlying ASD.

Synaptic Pathology

LRRTM3's role in synapse formation and function directly aligns with the synaptic dysfunction hypothesis of autism. The protein's ability to organize excitatory synapses through neurexin and PTPσ binding may be particularly relevant to ASD pathogenesis [4][7].

Role in Bipolar Disorder

Targeted sequencing of the LRRTM gene family in suicide attempters with bipolar disorder identified rare variants in LRRTM3, suggesting potential involvement in mood disorder pathophysiology [11]. This connection may relate to synaptic dysfunction in mood disorders.

Expression Pattern

Brain Regional Expression

LRRTM3 exhibits region-specific expression in the central nervous system:

Highest Expression: Cerebral cortex (layers 2-4), hippocampus (CA1-CA3 pyramidal cells), visual cortex
Moderate Expression: Cerebellum, thalamus, amygdala
Lower Expression: Brainstem, spinal cord

Cellular Localization

Primary Location: Postsynaptic membranes of excitatory synapses
Presynaptic Presence: Axon terminals (lower levels)
Subcellular Distribution: Concentrated in the postsynaptic density (PSD)

Developmental Expression

LRRTM3 expression peaks during early postnatal development (P7-P21 in mice), corresponding to the critical period of synapse formation and circuit refinement. Expression decreases in adulthood but remains elevated in regions undergoing continuous synaptic plasticity [10].

Protein-Protein Interactions

Neurexin Binding

LRRTM3 binds to presynaptic neurexin proteins through its LRR domain. This binding is:

Regulated by alternative splicing at neurexin splice site 4 (SS4)
Modulated by calcium ion binding
Competitively regulated by other LRRTM family members

PTPσ Interaction

LRRTM3 interacts with the receptor-type protein tyrosine phosphatase PTPσ (PTPRS), providing a postsynaptic signaling mechanism for synapse organization [4].

APP and BACE1 Interaction

LRRTM3 physically interacts with:

Amyloid precursor protein (APP)
Beta-secretase (BACE1)
Presenilin components of the gamma-secretase complex

LRRTM Family Comparison

Family Members

The LRRTM (Leucine-Rich Repeat Transmembrane Neuronal) family consists of four members [3][15]:

| Gene | Chromosome | Expression Pattern | Key Functions |
|------|-------------|-------------------|---------------|
| LRRTM1 | 2p21 | Cortex, hippocampus | Synapse formation, sociability |
| LRRTM2 | 5q31.3 | Broad CNS expression | Excitatory synaptogenesis |
| LRRTM3 | 10q21.3 | Hippocampus, visual cortex | Circuit-specific function |
| LRRTM4 | 12p12.3 | Cortex, cerebellum | AMPAR trafficking |

Functional Specialization

Each LRRTM has distinct binding properties and functions [14]:

LRRTM1: Known for social behavior; rare variants associated with autism LRRTM2: Most broadly expressed; canonical excitatory synaptogenesis LRRTM3: Specialized in specific circuits; visual system function LRRTM4: Enriched in cerebellum; motor learning involvement

Neurexin Binding Specificity

LRRTMs differ in their neurexin splice site preferences [2]:

LRRTM1/2: Prefer SS4+ neurexin (with splice site 4 insert)
LRRTM3/4: Broader binding, including SS4- neurexin
Competition: LRRTMs compete for neurexin binding

Differential Signaling Mechanisms

Each LRRTM activates distinct intracellular pathways:

| LRRTM | Primary Signaling | Synaptic Effect |
|-------|-------------------|-----------------|
| LRRTM1 | PSD-95 recruitment | Social behavior modulation |
| LRRTM2 | AMPAR recruitment | General synaptogenesis |
| LRRTM3 | Activity-dependent plasticity | Circuit refinement |
| LRRTM4 | Cerebellar pathways | Motor learning |

Detailed APP and BACE1 Interaction

Molecular Mechanism

LRRTM3 interacts with APP and BACE1 through distinct domains [4][5]:

APP Interaction Interface: Cytoplasmic tail binds APP intracellular domain, enabling potential bidirectional signaling and influencing APP trafficking.

BACE1 Colocalization: Accumulates in synaptic compartments with BACE1, potentially regulating BACE1 activity locally and providing spatial regulation of amyloidogenesis.

Genetic Evidence for AD Association

Multiple studies support LRRTM3 in AD risk [4][5]:

GWAS signals: LRRTM3 region shows suggestive association
Linkage studies: LOD scores support AD linkage
Expression studies: Altered expression in AD brains
Functional studies: Cell biology supports mechanism

Therapeutic Implications

Despite complexity, LRRTM3 offers therapeutic opportunities:

Modulate APP processing locally at synapses
Develop targeted delivery to neurons
Consider timing for intervention

Synaptic Transmission Mechanisms

Postsynaptic Organization

LRRTM3 organizes the postsynaptic density [1][2]:

Direct interaction with AMPAR subunits
Links to PSD-95 family proteins
Activity-dependent recruitment

Presynaptic Differentiation

LRRTM3 can induce presynaptic specialization [3]:

Neurexin binding triggers release machinery assembly
Regulates vesicle pool size
Controls release probability
Activity-dependent modulation

Activity-Dependent Synchronization

Recent work reveals LRRTM3 function in circuit refinement [1]:

Aligns pre- and postsynaptic properties
Matches release probability to receptor density
Ensures efficient transmission
Required for proper hippocampal circuit organization

Role in Visual System Development

Retinogeniculate Connectivity

LRRTM3 is essential for visual pathway formation [16]:

High expression in visual cortex
Required for proper retinogeniculate refinement
Supports high-acuity vision

Visual Processing Disorders

Dysregulation may contribute to:

Strabismus, amblyopia, processing deficits

Research Models and Methods

In Vitro Models

Neuronal cultures: Primary hippocampal/cortical neurons
Cell lines: HEK293, N2a for biochemistry
iPSC-derived neurons: Patient-specific models
Organoids: Cerebral organoids for development

In Vivo Models

Knockout mice: Lrrtm3^-/- phenotype analysis
Transgenic mice: Human LRRTM3 expression
Knock-in models: Patient mutations
Conditional knockouts: Region-specific deletion

Experimental Approaches

Electrophysiology: Whole-cell recordings, field potentials
Live imaging: Calcium imaging, FM dye recycling
Biochemistry: IP, biochemistry, proteomics

Therapeutic Development

Target Validation

LRRTM3 as a therapeutic target:

Genetic validation in AD and ASD
Mechanism supports biological plausibility
Expression in target tissues

Approach Strategies

Small Molecule Modulation: Agonists to enhance synaptic function
Protein-Based Therapy: Recombinant LRRTM3 protein
Gene Therapy: AAV-mediated expression

Challenges

Complex binding interactions
Region-specific functions
Compensatory mechanisms

Therapeutic Implications

Drug Target Potential

LRRTM3 represents a potential therapeutic target for:

Alzheimer's Disease: Modulating APP processing and synaptic function
Autism Spectrum Disorder: Restoring synaptic adhesion function
Sensory Processing Disorders: Enhancing circuit refinement

Challenges

The dispensability of LRRTM3 for amyloid-beta production in vivo suggests compensatory mechanisms
Complex interactions with multiple synaptic partners
Region-specific functions may require targeted delivery

Evolutionary Biology

Gene Family Origins

The LRRTM gene family emerged through duplication events [10]:

Ancestral LRRTM present in early vertebrates
Two rounds of duplication created current family
Subfunctionalization led to distinct expressions

Conservation Patterns

| Species | LRRTM3 Homolog | Amino Acid Identity |
|---------|-----------------|---------------------|
| Human | LRRTM3 | 100% |
| Mouse | Lrrtm3 | 96% |
| Rat | Lrrtm3 | 95% |
| Chicken | LRRTM3 | 88% |
| Zebrafish | lrrtm3 | 72% |
| Frog | lrrtm3 | 75% |

Functional Conservation

Key functional domains are highly conserved:

LRR domain: >90% identical across species
FNIII domain: Moderately conserved
Intracellular tail: Variable but functional

Mechanistic Models

LRRTM3 in Synaptic Organization

Mermaid diagram (expand to render)

Molecular Mechanism of Synaptic Adhesion

LRR Domain Structure

The leucine-rich repeat (LRR) domain forms a characteristic solenoid structure:

10 LRR motifs each of ~20 amino acids
Conserved flanking sequences (LRRNT, LRRCT)
Curved shape for protein-protein interactions
Calcium binding stabilizes the structure

Neurexin Binding Mechanics

LRRTM3-neurexin binding involves:

Hydrophobic interactions in LRR groove
Electrostatic complementarity
Splice site-dependent affinity (SS4+ > SS4-)
Competitive displacement by other LRRTMs

Clinical Implications

Neurodevelopmental Disorders

LRRTM3 variants contribute to multiple conditions:

Autism Spectrum Disorder: Rare coding variants
Intellectual Disability: De novo mutations
Language Disorders: Expression studies
Epilepsy: Some associations reported

Alzheimer's Disease Risk

The AD connection remains complex:

GWAS signals are suggestive, not definitive
Expression changes in AD brains observed
Interaction with APP suggests biological mechanism
Mouse models show complexity

Pharmacological Considerations

Druggability Assessment

LRRTM3 as a drug target:

Extracellular domain: Accessible to biologics
LRR domain: Potential small molecule binding
Intracellular signaling: Traditional small molecules
BBB penetration: Challenges for CNS drugs

Therapeutic Strategies

| Approach | Advantages | Challenges |
|----------|------------|-------------|
| Agonist antibodies | High specificity | Delivery to brain |
| Peptide mimetics | Cell penetration | Stability |
| Gene therapy | Long-term effect | Viral delivery |
| Small molecules | Oral bioavailability | Target specificity |

External Links

[NCBI Gene: LRRTM3](https://www.ncbi.nlm.nih.gov/gene/285220)
[UniProt: Q86VH5](https://www.uniprot.org/uniprot/Q86VH5)
[OMIM: 611242](https://www.omim.org/entry/611242)
[Ensembl: ENSG00000163220](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163220)

References

[Kim et al., LRRTM3 regulates activity-dependent synchronization of synapse properties in topographically connected hippocampal neural circuits (2022)](https://pubmed.ncbi.nlm.nih.gov/35022233/)

[Um et al., LRRTM3 Regulates Excitatory Synapse Development through Alternative Splicing and Neurexin Binding (2016)](https://pubmed.ncbi.nlm.nih.gov/26776509/)

[Dutta et al., LRRTM3 Genetic Variations and Autism Spectrum Disorder Trait Severity (2023)](https://pubmed.ncbi.nlm.nih.gov/39006200/)

[Lincoln et al., LRRTM3 interacts with APP and BACE1 in Late-Onset Alzheimer's Disease (2013)](https://pubmed.ncbi.nlm.nih.gov/23750206/)

[Majercak et al., LRRTM3 promotes APP processing by BACE1 (2006)](https://pubmed.ncbi.nlm.nih.gov/17098871/)

[Roppongi et al., LRRTMs Organize Synapses through Differential Engagement of Neurexin and PTPσ (2020)](https://pubmed.ncbi.nlm.nih.gov/31995730/)

[Linhoff et al., LRRTM family function (2009)](https://doi.org/10.1016/j.neuron.2009.09.019)

[Soler-Llavona et al., LRRTM3 and synapse formation (2010)](https://doi.org/10.1073/pnas.1003100107)

[Laakso et al., LRRTM3 is dispensable for amyloid-beta production in mice (2012)](https://pubmed.ncbi.nlm.nih.gov/22710909/)

[Uvarov et al., Origin and loss of nested LRRTM/α-catenin genes during vertebrate evolution (2014)](https://pubmed.ncbi.nlm.nih.gov/24587117/)

[Reichman et al., Targeted sequencing of the LRRTM gene family in bipolar disorder (2020)](https://pubmed.ncbi.nlm.nih.gov/31854516/)

[Lee et al., Juvenile-to-adult refinement of thalamic reticular circuits via LRRTM3 (2026)](https://pubmed.ncbi.nlm.nih.gov/41709459/)

[Siddique et al., LRRTM3 and visual processing (2019)](https://pubmed.ncbi.nlm.nih.gov/31424678/)

[Takashima et al., LRRTM3 in hippocampal development (2011)](https://pubmed.ncbi.nlm.nih.gov/21876680/)

[Schroeder et al., LRRTM family in synaptic organization (2018)](https://pubmed.ncbi.nlm.nih.gov/29896912/)

[Bissen et al., LRRNT proteins in neural development (2019)](https://pubmed.ncbi.nlm.nih.gov/30862345/)

[Ko et al., LRRTMs function as excitatory synapse organizers (2015)](https://pubmed.ncbi.nlm.nih.gov/25588838/)

[Takahashi et al., Postsynaptic SS4-neurexin binding to LRRTMs (2018)](https://pubmed.ncbi.nlm.nih.gov/29654274/)

[Wang et al., LRRTM3 and neuropsychiatric disorders (2018)](https://pubmed.ncbi.nlm.nih.gov/29568676/)

📖 View canonical wiki page →

Related Entities

LRRTM3

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-lrrtm3
kg_node_id	LRRTM3
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-1adf233c78e1
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-lrrtm3'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

25%

Debates

0

Incoming

5

Outgoing

7

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

LRRTM3 Gene

LRRTM3 (Leucine-Rich Repeat Transmembrane Neuronal 3)

Overview

LRRTM3 (Leucine-Rich Repeat Transmembrane Neuronal 3)

Overview

Molecular Structure and Biochemistry

Protein Architecture

Isoforms and Alternative Splicing

Physiological Functions

Excitatory Synapse Formation

Hippocampal Circuit Development

Thalamic Reticular Circuit Development

Visual Pathway Development

Role in Alzheimer's Disease

Genetic Association

APP Processing

Amyloid-Beta Production

Synaptic Dysfunction in AD

Role in Autism Spectrum Disorder

Genetic Evidence

Synaptic Pathology

Role in Bipolar Disorder

Expression Pattern

Brain Regional Expression

Cellular Localization

Developmental Expression

Protein-Protein Interactions

Neurexin Binding

PTPσ Interaction

APP and BACE1 Interaction

LRRTM Family Comparison

Family Members

Functional Specialization

Neurexin Binding Specificity

Differential Signaling Mechanisms

Detailed APP and BACE1 Interaction

Molecular Mechanism

Genetic Evidence for AD Association

Therapeutic Implications

Synaptic Transmission Mechanisms

Postsynaptic Organization

Presynaptic Differentiation

Activity-Dependent Synchronization

Role in Visual System Development

Retinogeniculate Connectivity

Visual Processing Disorders

Research Models and Methods

In Vitro Models

In Vivo Models

Experimental Approaches

Therapeutic Development

Target Validation

Approach Strategies

Challenges

Therapeutic Implications

Drug Target Potential

Challenges

Evolutionary Biology

Gene Family Origins

Conservation Patterns

Functional Conservation

Mechanistic Models

LRRTM3 in Synaptic Organization

Circuit Refinement Model

Molecular Mechanism of Synaptic Adhesion

LRR Domain Structure

Neurexin Binding Mechanics

Clinical Implications

Neurodevelopmental Disorders

Alzheimer's Disease Risk

Pharmacological Considerations

Druggability Assessment

Therapeutic Strategies

See Also

External Links

References

💬 Discussion